Skip to main content


Log in

Serum hyaluronan levels in patients with knee osteoarthritis

  • Original Article
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript


We examined the association between clinical parameters of disease activity and serum hyaluronic acid (HA) level in patients with knee osteoarthritis (OA). Fifty-eight patients with knee OA and 40 healthy individuals were included in this study. Demographic data were noted. The radiological evaluation was done according to Kellgren/Lawrence Grading System. Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) was used in evaluating the clinical disability caused by OA. Erythrocyte sedimentation rate (ESR) and serum C-reactive protein (CRP) level were determined in laboratory evaluations. Serum HA levels (in nanogram per milliliter) of both groups were measured by enzyme-linked immunosorbent assay. The mean ages of patients in OA group and control group were 57.58 (9.55) and 43.3(10.2) years, respectively. There was a significant difference between HA levels of both groups (p = 0.02). Also, there was a significant correlation between HA level and disease duration (p = 0.04), ESR (p = 0.001), and CRP level (p < 0.001). However, there was no significant correlation between HA levels with WOMAC and radiological grade (p > 0.05). There is no satisfactory amount of data regarding HA level in OA. In our study, we demonstrated that HA was in high levels in the serum of patients with OA. We suggest that serum HA levels may be used as a marker to determine the disease activity.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others


  1. Elliott AL, Kraus VB, Luta G, Stabler T, Renner JB, Woodard J, Dragomir AD, Helmick CG, Hochberg MC, Jordan JM (2005) Serum hyaluronan levels and radiographic knee and hip osteoarthritis in African Americans and Caucasians in the Johnston County Osteoarthritis Project. Arthritis Rheum 52:105–111

    Article  PubMed  CAS  Google Scholar 

  2. Sharif M, George E, Shepstone L, Knudson W, Thonar EJ, Cushnaghan J, Dieppe P (1995) Serum hyaluronic acid level as a predictor of disease progression in osteoarthritis of the knee. Arthritis Rheum 38:760–767

    Article  PubMed  CAS  Google Scholar 

  3. Garnero P, Rousseau JC, Delmas PD (2000) Molecular basis and clinical use of biochemical markers of bone, cartilage, and synovium in joint diseases. Arthritis Rheum 43:953–968

    Article  PubMed  CAS  Google Scholar 

  4. Wells AF, Klareskog L, Lindblad S, Laurent TC (1992) Correlation between increased hyaluronan localized in arthritic synovium and the presence of proliferating cells: a role for macrophage-derived factors. Arthritis Rheum 35:391–396

    Article  PubMed  CAS  Google Scholar 

  5. Laurent TC, Dahl IM, Dahl LB, Engstrom-Laurent A, Eriksson S, Fraser JR, Granath KA, Laurent C, Laurent UB, Lilja K et al (1986) The catabolic fate of hyaluronic acid. Connect Tissue Res 15:33–41

    PubMed  CAS  Google Scholar 

  6. Hallgren R, Engstrom-Laurent A, Nisbeth U (1987) Circulating hyaluronate: a potential marker of altered metabolism of the connective tissue in uremia. Nephron 46:150–154

    Article  PubMed  CAS  Google Scholar 

  7. Wilkinson CR, Bower LM, Warren C (1996) The relationship between hyaluronidase activity and hyaluronic acid concentration in sera from normal controls and from patients with disseminated neoplasm. Clin Chim Acta 256:165–173

    Article  PubMed  CAS  Google Scholar 

  8. Manley G, Warren C (1987) Serum hyaluronic acid in patients with disseminated neoplasm. J Clin Pathol 1987 40:626–630

    Article  CAS  Google Scholar 

  9. Faber J, Horslev-Petersen K, Perrild H, Lorenzen I (1990) Different effects of thyroid disease on serum levels of procollagen III N-peptide and hyaluronic acid. J Clin Endocrinol Metab 71:1016–1021

    Article  PubMed  CAS  Google Scholar 

  10. Ozasa H, Chichibu K, Tanaka Y, Kondo T, Kitajima K, Ota K (1992) Relationship between plasma levels of hyaluronic acid and amyloid-associated osteoarthropathy in chronic hemodialysis patients. Nephron 61:187–191

    PubMed  CAS  Google Scholar 

  11. Engstrom-Laurent A, Hallgren R (1985) Circulating hyaluronate in rheumatoid arthritis: relationship to inflammatory activity and the effect of corticosteroid therapy. Ann Rheum Dis 44:83–88

    Article  PubMed  CAS  Google Scholar 

  12. Lundin A, Engstrom-Laurent A, Hallgren R, Michaelsson G (1985) Circulating hyaluronate in psoriasis. Br J Dermatol 112:663–671

    Article  PubMed  CAS  Google Scholar 

  13. Nishida Y, D’Souza AL, Thonar EJM, Knudson W (2000) Stimulation of hyaluronan metabolism by interleukin 1α in human articular cartilage. Arthritis Rheum 43:1315–1326

    Article  PubMed  CAS  Google Scholar 

  14. Altman RD (1991) Criteria for classification of clinical osteoarthritis. J Rheumatol 18(Suppl 27):19–23

    Google Scholar 

  15. Kellgren JH, Lawrence JS (eds) (1963) The epidemiology of chronic rheumatism, atlas of standard radiographs. Blackwell, Oxford, UK

    Google Scholar 

  16. Bellamy N, Buchanan WW, Goldsmith CH, Campbell J, Stitt L (1988) Validation study of WOMAC: a health status instrument for measuring clinically-important patient relevant outcomes following total hip or knee arthroplasty in osteoarthritis. J Orthop Rheumatol 1:95–108

    Google Scholar 

  17. Weigel JA, Raymond RC, McGary C, Singh A, Weigel PH (2003) A blocking antibody to the hyaluronan receptor for endocytosis (HARE) inhibits hyaluronan clearance by perfused liver. J Biol Chem 278:9808–9812

    Article  PubMed  CAS  Google Scholar 

  18. Poole AR, Witter J, Roberts N, Piccolo F, Brandt R, Paquin J, Baron M (1990) Inflammation and cartilage metabolism in rheumatoid arthritis: studies of the blood markers hyaluronic acid, orosomucoid, and keratan sulfate. Arthritis Rheum 33:790–799

    Article  PubMed  CAS  Google Scholar 

  19. Manicourt DH, Triki R, Fukuda K, Devogelaer JP, de Deuxchasnes CN, Thonar EJ (1993) Levels of circulating tumor necrosis factor and interleukin-6 in patients with rheumatoid arthritis: relationship to serum levels of hyaluronan and antigenic keratan sulfate. Arthritis Rheum 36:490–499

    Article  PubMed  CAS  Google Scholar 

  20. Hedin PJ, Weitoft T, Hedin H, Engstrom-Laurent A, Saxne T (1991) Serum concentrations of hyaluronan and proteoglycan in joint disease: lack of association. J Rheumatol 18:1601–1605

    PubMed  CAS  Google Scholar 

  21. Emlen W, Niebur J, Flanders G, Rutledge J (1996) Measurement of serum hyaluronic acid in patients with rheumatoid arthritis: correlation with disease activity. J Rheumatol 23:974–978

    PubMed  CAS  Google Scholar 

  22. Sharma L, Hurwitz DE, Thonar EJ, Sum JA, Lenz ME, Dunlop DD, Schnitzer TJ, Kirwan-Mellis G, Andriacchi TP (1998) Knee adduction moment, serum hyaluronan level, and disease severity in medial tibiofemoral osteoarthritis. Arthritis Rheum 41(7):1233–1240

    Article  PubMed  CAS  Google Scholar 

  23. Thonar EJ, Masuda K, Lenz ME, Hauselmann HJ, Kuettner KE, Manicourt DH (1995) Serum markers of systemic disease processes in osteoarthritis. J Rheumatol Suppl 43:68–70

    PubMed  CAS  Google Scholar 

  24. Goldberg RL, Huff JP, Lenz ME, Glickman P, Katz R, Thonar EJ (1991) Elevated plasma levels of hyaluronate in patients with osteoarthritis and rheumatoid arthritis. Arthritis Rheum 34:799–807

    Article  PubMed  CAS  Google Scholar 

  25. Sowers M, Jannausch M, Stein E, Jamadar D, Hochberg M, Lachance L (2002) C-reactive protein as a biomarker of emergent osteoarthritis. Osteoarthr Cartil 10:595–601

    Article  PubMed  Google Scholar 

  26. Spector TD, Hart DJ, Nandra D, Doyle DV, Mackillop N, Gallimore JR, Pepys MB (1997) Low-level increases in serum C-reactive protein are present in early osteoarthritis of the knee and predict progressive disease. Arthritis Rheum 40:723–727

    Article  PubMed  CAS  Google Scholar 

  27. Horslev-Petersen K, Bentsen KD, Engström-Laurent A, Junker P, Halberg P, Lorenzen I (1988) Serum amino terminal type III procollagen peptide and serum hyaluronan in rheumatoid arthritis: relation to clinical and serological parameters of inflammation during 8 and 24 months treatment with levamisole, penicillamine, or azothioprine. Ann Rheum Dis 47:116–126

    PubMed  CAS  Google Scholar 

  28. Levesque H, Delpech B, Le Loet X, Deshayes P (1988) Serum hyaluronate in rheumatoid arthritis: study by affino-immunoenzymatic assay. Br J Rheumatol 27:445–449

    Article  PubMed  CAS  Google Scholar 

  29. Di Cesare PE, Abramson SB (2005) Pathogenesis of osteoarthritis. In: Harris ED (ed) Kelley’s textbook of rheumatology, 7th edn. Elsevier, Philadelphia, PA, pp 1493–1513

    Google Scholar 

Download references

Author information

Authors and Affiliations


Corresponding author

Correspondence to Yasemin Turan.

Additional information

This manuscript has been accepted as poster presentation in the Annual European Congress of Rheumatology, 8–11 June 2005, in Vienna, Austria.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Turan, Y., Bal, S., Gurgan, A. et al. Serum hyaluronan levels in patients with knee osteoarthritis. Clin Rheumatol 26, 1293–1298 (2007).

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: